Enhancing the role played by clinical pharmacists in psychiatric settings to better integrate clinical psychopharmacology into the decision-making process

Javelot, Hervé; Dizet, Sophie; Straczek, Céline; Langrée, B.; Michel, Bruno; Haffen, Emmanuel; Bertschy, Gilles

doi:10.1016/j.therap.2020.12.011

Cited by 4 publications

(12 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, simplistic categorical diagnoses are abundantly used in contemporary psychiatric practice and have contributed to pharmacotherapy choices dictated by guidelines/algorithms [4,68]. Therefore, this decline in clinical curiosity in favour of a more standardized approach is potentially associated with impoverishing clinicians' knowledge of the pharmacological tools available [4,68].…”

Section: Shared Expertise In Clinical Psychopharmacology Between Psychiatric Pharmacist and Psychiatrist: Why And How?mentioning

confidence: 99%

“…For several years now, we have created in France a local skills network specializing in psychopharmacology [4,69]. Recent data bear witness to the fact that this network of expertise, involving both psychiatric pharmacists and psychiatrists, receives a large and growing number of requests, with a high level of satisfaction expressed by the doctors requesting it [4]. This system is also proving effective in terms of publications and in particular for formalizing professional recommendations [4].…”

Section: Shared Expertise In Clinical Psychopharmacology Between Psychiatric Pharmacist and Psychiatrist: Why And How?mentioning

confidence: 99%

“…Clinical Pharmacy is generally considered to have originated in the USA in the 1960s, while the supervising associations such as the American College of Clinical Pharmacy (ACCP) and the European Society of Clinical Pharmacy (ESCP) were created in 1979 [1][2][3]. English speaking countries, and the USA in particular, continue to serve as a benchmark in advancing clinical pharmacy [4]. One of the strongest axes of clinical pharmacy in English speaking countries is based on its specialization and the vision for the future expressed by the ACCP is that "most clinical pharmacy practitioners will be board certified specialists" [5].…”

Section: Introductionmentioning

confidence: 99%

“…The American Pharmaceutical Association created the Board of Pharmaceutical Specialties (BPS) in 1976 in order to create certification to qualified pharmacists, notably in pharmacotherapy (since 1988) and psychiatric pharmacy (since 1992) [5]. Interestingly, it appears that the pharmacist's qualification as a "drug specialist" may be called into question in the context of the practice of clinical pharmacy in some non-English-speaking countries [4]. The doctor of pharmacy degree (PharmD) may not be sufficient on its own, and may even require a "board-certified pharmacotherapy specialization".…”

Section: Introductionmentioning

confidence: 99%

“…While recent publications continue to demonstrate the interest and scalability of clinical pharmacy in psychiatry [4,[8][9][10], its deployment continues to be held back for various reasons [3,4,11,12].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology

et al. 2021

Self Cite

View full text Add to dashboard Cite

Although clinical pharmacy is a discipline that emerged in the 1960s, the question of precisely how pharmacists can play a role in therapeutic optimization remains unanswered. In the field of mental health, psychiatric pharmacists are increasingly involved in medication reconciliation and therapeutic patient education (or psychoeducation) to improve medication management and enhance medication adherence, respectively. However, psychiatric pharmacists must now assume a growing role in team-based models of care and engage in shared expertise in psychopharmacology in order to truly invest in therapeutic optimization of psychotropics. The increased skills in psychopharmacology and expertise in psychotherapeutic drug monitoring can contribute to future strengthening of the partnership between psychiatrists and psychiatric pharmacists. We propose a narrative review of the literature in order to show the relevance of a clinical pharmacist specializing in psychiatry. With this in mind, herein we will address: (i) briefly, the areas considered the basis of the deployment of clinical pharmacy in mental health, with medication reconciliation, therapeutic education of the patient, as well as the growing involvement of clinical pharmacists in the multidisciplinary reflection on pharmacotherapeutic decisions; (ii) in more depth, we present data concerning the use of therapeutic drug monitoring and shared expertise in psychopharmacology between psychiatric pharmacists and psychiatrists. These last two points are currently in full development in France through the deployment of Resource and Expertise Centers in PsychoPharmacology (CREPP in French).

show abstract